Hak-Hyun Nam
Founder at I-SENS, INC.
Net worth: 26 M $ as of 30/05/2024
Hak-Hyun Nam active positions
| Companies | Position | Start | End |
|---|---|---|---|
| I-SENS, INC. | Director/Board Member | 03/05/2000 | - |
| Chief Executive Officer | - | - | |
| Founder | 03/05/2000 | - | |
| Chief Tech/Sci/R&D Officer | 03/05/2000 | - | |
| President | 30/03/2015 | - | |
| PRECISION BIOSENSOR, INC. | Director/Board Member | - | - |
| I Sense Jiangsu Co., Ltd. | Director/Board Member | - | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - | - |
Career history of Hak-Hyun Nam
Training of Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Statistics
International
| United States | 3 |
| South Korea | 2 |
| 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Precision Biosensor, Inc. | |
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
- Stock Market
- Insiders
- Hak-Hyun Nam
- Experience
